Inhibition of alpha-synuclein fibrillization by dopamine is mediated by interactions with five C-terminal residues and with E83 in the NAC region.
The interplay between dopamine and alpha-synuclein (AS) plays a central role in Parkinson's disease (PD). PD results primarily from a severe and selective devastation of dopaminergic neurons in substantia nigra pars compacta. The neuropathological hallmark of the disease is the presence of intr...
Main Authors: | Fernando E Herrera, Alessandra Chesi, Katerina E Paleologou, Adrian Schmid, Adriana Munoz, Michele Vendruscolo, Stefano Gustincich, Hilal A Lashuel, Paolo Carloni |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2008-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2566601?pdf=render |
Similar Items
-
Modulation of alpha-synuclein aggregation by dopamine analogs.
by: Diane Latawiec, et al.
Published: (2010-02-01) -
Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports
by: Hilal A. Lashuel
Published: (2020-07-01) -
Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils
by: Mustafa T. Ardah, et al.
Published: (2015-02-01) -
Administration of AAV-Alpha Synuclein NAC Antibody Improves Locomotor Behavior in Rats Overexpressing Alpha Synuclein
by: Yun-Hsiang Chen, et al.
Published: (2021-06-01) -
Inhibition of alpha-synuclein seeded fibril formation and toxicity by herbal medicinal extracts
by: Mustafa T. Ardah, et al.
Published: (2020-03-01)